Medically reviewed by Archana Sharma, DO Key Takeaways Colon cancer treatment depends on the stage, tumor characteristics, ...

Diagnostic and surgical approaches to treating the disease are evolving — just as rates are spiking. Learn how the surgical ...

When someone is diagnosed with colorectal cancer—which includes both colon and rectal cancers—many people immediately think "surgery." And it's true that surgery plays a central role in treatment for ...

A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific ...

In the phase 3 EMT2 trial, high-dose EPA was associated with longer overall survival but not improved progression-free ...

The approach only works for a specific genetic subtype of bowel cancer, and the researchers now say they can predict who it works for.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced early Phase 2 results from the mismatch ...

High-dose omega-3 fatty acid supplements might improve survival among some patients with advanced colon cancer, a new study ...

In pMMR/MSS colon cancer, neoadjuvant BOT+BAL met the trial’s primary endpoint with a 36% major pathologic response rate, ...

Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world ...

An 85-year-old woman with a positive Cologuard test seeks guidance after her gastroenterologist declined a colonoscopy.